Canada-based clinical-stage biotech Zymeworks today announced positive top-line results from the Phase III HERIZON-GEA-01 ...

Established by ADQ, an active sovereign investor focused on critical infrastructure and global supply chains, Arcera is ...

Belgium-based Agomab Therapeutics today announced positive data from 103 participants completing 12 weeks of treatment in the ...

Sofinnova Partners, a European life sciences venture capital firm based in Paris, London and Milan, today announced the close ...

Export Barbados (BIDC) and EarlyHealth Group (EHG), headquartered in Dubai, United Arab Emirates, have signed a Letter of Intent to jointly establish EarlyHealth City Barbados, a $200 million ...

The European Federation of Pharmaceuticals Industries and Associations (EFPIA) and Vaccine Europe (VE) are calling for clear, ...

Last week saw the end of the bidding war for Metsera, with the company accepting an improved offer from Pfizer and counter ...

Between the US government shutdown, crippling international tariffs, debilitating funding cuts to critical research, and the ...

The European Medicines Agency’s EMA’s human medicines committee (CHMP) recommended seven novel medicines for approval at its ...

The race to find a new treatment for hair loss hotted up last month with two mega funding rounds for Pelage Pharmaceuticals and Veradermics. The deals also demonstrated biopharma’s growing interest in ...

US pharma major Bristol Myers Squibb—in collaboration with Johnson & Johnson—has announced the decision to stop the Phase III ...

TandemAI has announced that it has secured a $22 million Series A extension to further develop its drug discovery platform, ...